Ads
related to: fda, cancer drug- Overall Survival Results
See Updated Overall Survival Data
For This Treatment Option
- Dosing & Administration
Read More About Dosing
And How To Prescribe
- Patient Support
View The The Service Request Form
To Gain Access To Support Programs
- Safety Profile
View The Full Safety Profile And
See Side Effects For This Option
- Official Video Library
See A Medical Expert Discuss
Overall Survival Data For mBC
- Financial Resources
Learn About The Available Access
Programs For Your Patients
- Overall Survival Results
Search results
New Cancer 'Missile' Drugs May Be More Effective Than Traditional Chemotherapy
Verywell Health via Yahoo News· 7 hours agoExperts say this class of drug is exciting as it might be more effective than conventional...
FDA misses own deadline to propose ban on cancer-linked formaldehyde from hair relaxers
The Today Show via AOL· 3 hours agoThe FDA announced it would propose a ban on formaldehyde commonly found in hair relaxers typically...
FDA approves Alecensa as leading-edge adjuvant therapy for ALK-positive lung cancer
Clinical Trials Arena via Yahoo Finance· 9 hours agoOn 18 April 2024, the US Food and Drug Administration (FDA) approved Roche’s Alecensa (alectinib),...
Oops They Did It Again: FDA Misses Deadline To Propose A Ban On Formaldehyde, The Chemical Often...
Essence· 3 hours agoThe U.S. Food and Drug Administration (FDA) failed to meet their own deadline in April to issue a...
Wisconsin high school football coach unable to get chemo due to shortage dies at 60
NBC News via Yahoo News· 2 days agoLast summer, NBC News reported that 14 drugs used in cancer treatment were hard to come by. In April...
FDA Disregards Deadline To Ban Cancerous Formaldehyde Found In Hair Relaxers
Black Enterprise· 3 hours agoThe Food and Drug Administration missed its own deadline to ban formaldehyde in hair-straightening products. The FDA hasn’t released a statement on why ...
US FDA grants full approval for Pfizer's cervical cancer drug
AOL· 3 days agoThe treatment, Tivdak - an antibody-drug conjugate co-developed by Genmab A/S and Seagen - received the FDA's accelerated approval for the same indication ...
Project Optimus: helping or hindering cancer drug development?
Clinical Trials Arena via Yahoo Finance· 14 hours agoAgency eyes have zeroed in on oncology, with the FDA Oncology Center of Excellence (OCE) introducing...
FDA grants full approval to cervical cancer drug TIVDAK By Investing.com
Investing.com· 3 days agoFood and Drug Administration (FDA) for TIVDAK® (tisotumab vedotin-tftv) for the treatment of...
Palatin Announces FDA Clearance of IND Application for the Co-Administration of Bremelanotide with...
WKBN 27 Youngstown· 11 hours ago(NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that ...
Ad
related to: fda, cancer drug
